Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1L1 | Q9UHC9 | 9/20 | 0.69 |
| ▸ | USP2 | O75604 | 3/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | POLA1 | P09884 | 1/20 | 0.52 |
| ▸ | TOP2A | P11388 | 1/20 | 0.52 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.52 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.52 |
| ▸ | OSBP | P22059 | 1/20 | 0.52 |
| ▸ | RORC | P51449 | 1/20 | 0.52 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.52 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.48 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18942513 | 1.00 | NPC1L1 (0.69) | NPC1L1USP2LMNAMEN1TP53 | |
| SCHEMBL1274095 | 1.00 | NPC1L1 (0.69) | NPC1L1USP2LMNAMEN1TP53 | |
| SCHEMBL6391738 | 0.91 | NPC1L1 (0.77) | NPC1L1USP2LMNAMEN1TP53 | |
| SCHEMBL6391742 | 0.91 | NPC1L1 (0.77) | NPC1L1USP2LMNAMEN1TP53 | |
| SCHEMBL18942518 | 0.90 | NPC1L1 (0.71) | NPC1L1USP2LMNAMEN1TP53 | |
| SCHEMBL11591548 | 0.89 | NPC1L1 (0.68) | NPC1L1USP2LMNAMEN1TP53 | |
| SCHEMBL11591551 | 0.89 | NPC1L1 (0.68) | NPC1L1USP2LMNAMEN1TP53 | |
| SCHEMBL21883667 | 0.88 | NPC1L1 (0.82) | NPC1L1USP2LMNAMEN1TP53 | |
| Acebrochol SCHEMBL9250494 | 0.85 | NPC1L1 (0.56) | NPC1L1USP2LMNAMEN1TP53 | |
| Acebrochol SCHEMBL1006383 | 0.85 | NPC1L1 (0.56) | NPC1L1USP2LMNAMEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3181576-B1 | METHOD FOR SYNTHESIZING 25-HYDROXY CHOLESTEROL | UNIV ZHEJIANG TECHNOLOGY (CN) | 2019-09-04 | — | — | EP | disclosed |
| US-9802977-B2 | Method of synthesizing 25-hydroxy cholesterol | ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) | 2017-10-31 | — | — | US | disclosed |
| EP-3181576-A1 | METHOD FOR SYNTHESIZING 25-HYDROXY CHOLESTEROL | Zhejiang University of Technology (CN) | 2017-06-21 | — | — | EP | disclosed |
| US-20170158729-A1 | METHOD OF SYNTHESIZING 25-HYDROXY CHOLESTEROL | ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) | 2017-06-08 | — | — | US | disclosed |
| CN-104130306-B | A kind of synthetic method of 25-HYDROXY CHOLESTEROL | JIANG University OF TECHNOLOGY (CN) | 2016-05-18 | — | — | CN | disclosed |
| CN-104130306-A | Method for synthesizing 25-hydroxy cholesterol | UNIV ZHEJIANG TECHNOLOGY | 2014-11-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158729-A1 | METHOD OF SYNTHESIZING 25-HYDROXY CHOLESTEROL | CYP46A1, HMGCR, DHCR7 | NPC1L1 124/4885USP2 890/4885LMNA 1752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.